603590.SS · 康辰药业
China A-shares · RS rating 14 · As of 2026-10-14
| Price | 28.02 CNY |
|---|---|
| 1-day change | -4.0% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 41 / 31 / 5 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 21 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +15.4% |
| Distance from 52-week high | +49.0% |
| Market cap (USD) | $752.3M |